Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2Withdrawn 1

Sponsor Class

NETWORK 3INDUSTRY 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3Genitourinary 1

Conditions

Breast Neoplasms 3

Interventions

Cyclophosphamide 42Docetaxel 33Paclitaxel 31Tamoxifen 29Doxorubicin 29Trastuzumab 25Radiotherapy 21Epirubicin 16Letrozole 15Anastrozole 12exemestane 11Fluorouracil 11Capecitabine 10Bevacizumab 10palbociclib 9Immunohistochemistry 9Fulvestrant 9Filgrastim 9Lapatinib 8Zoledronic Acid 7Methotrexate 7Magnetic Resonance Spectroscopy 7Gene Expression Profiling 7pertuzumab 6Triptorelin Pamoate 6Taxes 6Surgical Procedures, Operative 6Microarray Analysis 6Goserelin 6Chemotherapy, Adjuvant 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Clodronic Acid × Breast × Clear all
NCT00127205 2021-07-02

S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.

SWOG Cancer Research Network

Phase 3 Completed
6,097 enrolled 20 charts
Breast

Breast Neoplasms

NCT00009945 2017-12-13

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

NSABP Foundation Inc

Phase 3 Completed
3,323 enrolled 12 charts
Breast

Breast Neoplasms

NCT00873808 2013-04-10

S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307

SWOG Cancer Research Network

Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡